Incentives for Starting Small Companies Focused on Rare and Neglected Diseases

Pharmaceutical Research - United States
doi 10.1007/s11095-015-1841-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Current Pipelines for Neglected Diseases

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2014English

Reassessing Therapeutic Antibodies for Neglected and Tropical Diseases

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2020English

Neglected Tropical Diseases

BMJ
2007English

Indicators and Information Platforms Focused on Industries, Companies and Products

Material Cycles and Waste Management Research
2017English

Spotlight on Rare Diseases

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

2020: A Crucial Year for Neglected Tropical Diseases

The Lancet
Medicine
2019English

Spending on Neglected Diseases Has Increased, Says Report

BMJ
2004English

Innovative Partnerships for Drug Discovery Against Neglected Diseases

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2011English

The World's Most Neglected Diseases

BMJ
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy